A study for a 15 year old girl who takes Humalog - from FDA reports


Summary

906 females aged 15 (±5) who take the same drug are studied. This is a personalized study for a 15 year old female patient who has Type 1 Diabetes. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Oct, 14, 2017

906 females aged 15 (±5) who take Humalog are studied.


Number of reports submitted per year:

Humalog for a 15-year old girl.

Information of the patient in this study:

  • Age: 15
  • Gender: female
  • Conditions: Type 1 Diabetes
  • Drugs taken:
    • Humalog (insulin lispro recombinant)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Tremors: 9 (0.99% of females aged 15 (±5) who take the drug)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common side effects over time

< 1 month:
  • vision blurred
  • photophobia
  • diplopia
  • reading disorder
  • suicide attempt
  • hypoglycemia
  • hyperglycemia
  • intentional overdose
  • nervous system disorder
  • maternal exposure during pregnancy
1 - 6 months:
  • white blood cell count decreased
  • hepatic function abnormal
  • aspartate aminotransferase increased
  • alanine aminotransferase increased
  • gamma-glutamyltransferase increased
  • glycosylated haemoglobin increased
  • hepatomegaly
  • nausea
  • hepatocellular damage
  • diabetic retinopathy
6 - 12 months:
  • diabetic ketoacidosis
1 - 2 years:
  • blood glucose increased
  • diabetic ketoacidosis
  • pollakiuria
  • urinary tract infection
  • sluggishness
  • abdominal pain
  • malaise
  • feeling abnormal
  • confusion
  • trismus
2 - 5 years:
  • blood glucose increased
  • diabetic ketoacidosis
  • sinusitis
  • therapeutic response decreased
  • agranulocytosis
  • white blood cell count decreased
  • blood glucose fluctuation
  • arthritis
  • renal impairment
  • blood glucose decreased
5 - 10 years:
n/a
10+ years:
  • hypersensitivity
not specified:
  • blood glucose increased
  • diabetic ketoacidosis
  • drug ineffective
  • blood glucose decreased
  • hyperglycemia
  • nausea and vomiting
  • hypoglycemia
  • malaise
  • glycosylated haemoglobin increased
  • diabetes mellitus inadequate control

Top conditions involved for these people *:

  • Cystic Fibrosis (24 people, 2.65%)
  • Birth Control (16 people, 1.77%)
  • Depression (7 people, 0.77%)
  • Premenstrual Syndrome (6 people, 0.66%)
  • Pain (6 people, 0.66%)

Top co-used drugs for these people *:

  • Lantus (267 people, 29.47%)
  • Humulin R (46 people, 5.08%)
  • Levemir (30 people, 3.31%)
  • Pulmozyme (25 people, 2.76%)
  • Novolog (20 people, 2.21%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Tremors, Type 1 diabetes, Humalog

You may be interested in these reviews

More reviews for: Tremors, Type 1 diabetes, Humalog